As the SARS-CoV-2 pandemic evolves, new variants continue to emerge. Some highly transmissible variants, such as Delta, also raised concerns about the effectiveness provided by current vaccines. Understanding immunological correlates of protection and how laboratory findings correspond to clinical effectiveness is imperative to shape future vaccination strategies
The past several months have witnessed the emergence of SARS-CoV-2 variants with novel spike protein...
The world has not yet completely overcome the fear of the havoc brought by SARS-CoV-2. The virus has...
Vaccination has greatly reduced the disease burden of SARS-CoV-2. However, since late 2020, variants...
Introduction: COVID-19 vaccines have been developed to compact the current SARS-CoV-2 pandemic and h...
As of 25 January 2022, over 349 million individuals have received a confirmed diagnosis of covid-19,...
Since the COVID-19 pandemic first began in December 2019, the severe acute respiratory syndrome coro...
Coronavirus disease 19 (COVID-19) continues to challenge most scientists in the search of an effecti...
1,5 years into the pandemic, SARS-CoV-2 remains a dynamic and evolving disease. Growing proportions ...
Since the COVID-19 pandemic first began in December 2019, the severe acute respiratory syndrome coro...
The COVID-19 pandemic has led the world to undertake the largest vaccination campaign in human histo...
Efforts to mitigate the COVID-19 pandemic are underway, andvaccination is imposing selection pressur...
Viral variants of concern may emerge with dangerous resistance to the immunity generated by the curr...
The emergence of several new variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant (B.1.617.2) was the p...
Over the past two years, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused...
The past several months have witnessed the emergence of SARS-CoV-2 variants with novel spike protein...
The world has not yet completely overcome the fear of the havoc brought by SARS-CoV-2. The virus has...
Vaccination has greatly reduced the disease burden of SARS-CoV-2. However, since late 2020, variants...
Introduction: COVID-19 vaccines have been developed to compact the current SARS-CoV-2 pandemic and h...
As of 25 January 2022, over 349 million individuals have received a confirmed diagnosis of covid-19,...
Since the COVID-19 pandemic first began in December 2019, the severe acute respiratory syndrome coro...
Coronavirus disease 19 (COVID-19) continues to challenge most scientists in the search of an effecti...
1,5 years into the pandemic, SARS-CoV-2 remains a dynamic and evolving disease. Growing proportions ...
Since the COVID-19 pandemic first began in December 2019, the severe acute respiratory syndrome coro...
The COVID-19 pandemic has led the world to undertake the largest vaccination campaign in human histo...
Efforts to mitigate the COVID-19 pandemic are underway, andvaccination is imposing selection pressur...
Viral variants of concern may emerge with dangerous resistance to the immunity generated by the curr...
The emergence of several new variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant (B.1.617.2) was the p...
Over the past two years, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused...
The past several months have witnessed the emergence of SARS-CoV-2 variants with novel spike protein...
The world has not yet completely overcome the fear of the havoc brought by SARS-CoV-2. The virus has...
Vaccination has greatly reduced the disease burden of SARS-CoV-2. However, since late 2020, variants...